EP Global Communications, Inc. (PINKSHEETS: EPGL) will change its name to EPGL Medical Sciences, Inc. in early 2013. EPGL Medical Sciences, Inc. is a new biomedical device manufacturing and marketing company. The Company is focused on developing and marketing medical devices for both diagnosis and treatment of chronic pain. EPGL Med's first medical device, the MPDD, will be released in 2013 to awaiting physicians worldwide. The FDA cleared MPDD medical device can help physicians detect the exact point of pain origination in muscles as never before.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.